desipramine has been researched along with Coronary Artery Disease in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagawa, H | 1 |
| Yamazaki, T | 1 |
| Akiyama, T | 1 |
| Yahagi, N | 1 |
| Kawada, T | 1 |
| Mori, H | 1 |
| Sunagawa, K | 1 |
1 other study available for desipramine and Coronary Artery Disease
| Article | Year |
|---|---|
Modulatory effects of ketamine on catecholamine efflux from in vivo cardiac sympathetic nerve endings in cats.
Topics: Adrenergic Uptake Inhibitors; Animals; Calcium Channel Blockers; Catecholamines; Cats; Coronary Arte | 2002 |